🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 8 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/10/2017 4,23 4,42 4,21 4,36 +2,59% 4,96% 1.175.200
06/10/2017 4,35 4,43 4,20 4,25 -2,97% 5,29% 680.800
05/10/2017 4,35 4,43 4,24 4,38 -0,45% 4,37% 802.100
04/10/2017 4,53 4,53 4,32 4,40 -2,22% 4,64% 814.500
03/10/2017 4,50 4,53 4,34 4,50 +1,12% 4,11% 1.052.900
02/10/2017 4,48 4,54 4,33 4,45 +2,77% 4,69% 1.559.100
29/09/2017 4,26 4,42 4,12 4,33 +2,61% 6,97% 1.057.300
28/09/2017 4,01 4,34 4,00 4,22 +6,84% 8,48% 1.851.700
27/09/2017 3,65 4,02 3,65 3,95 +7,92% 10,14% 1.607.300
26/09/2017 3,78 3,87 3,64 3,66 -2,14% 6,08% 1.107.000
25/09/2017 3,60 3,79 3,58 3,74 +5,35% 5,83% 1.276.900
22/09/2017 3,49 3,58 3,40 3,55 +1,14% 5,16% 692.300
21/09/2017 3,52 3,66 3,40 3,51 -0,28% 7,39% 1.331.600
20/09/2017 3,26 3,59 3,24 3,52 +9,32% 10,61% 2.029.800
19/09/2017 3,35 3,37 3,03 3,22 -2,72% 10,15% 1.208.900
18/09/2017 3,61 3,67 3,23 3,31 +0,30% 12,19% 3.091.600
15/09/2017 2,76 3,43 2,75 3,30 +18,28% 24,64% 3.646.600
14/09/2017 3,51 3,53 2,65 2,79 -20,96% 24,93% 3.584.600
13/09/2017 3,44 3,74 3,40 3,53 +2,62% 9,88% 1.611.900
12/09/2017 3,52 3,89 3,39 3,44 +0,29% 14,12% 2.677.200
11/09/2017 3,16 3,55 3,16 3,43 +10,29% 12,34% 1.654.300
08/09/2017 3,35 3,40 3,04 3,11 -6,04% 10,75% 1.434.400
07/09/2017 3,04 3,42 2,95 3,31 +9,97% 15,46% 1.756.100
06/09/2017 3,02 3,06 2,88 3,01 +1,35% 5,96% 947.300
05/09/2017 2,86 3,10 2,81 2,97 +3,85% 10,14% 1.713.600
01/09/2017 2,84 2,89 2,73 2,86 +2,14% 5,63% 555.200
31/08/2017 2,78 2,84 2,68 2,80 +2,19% 5,72% 893.100
30/08/2017 2,67 2,95 2,64 2,74 +3,79% 11,61% 1.799.900
29/08/2017 2,67 2,77 2,56 2,64 -3,65% 7,83% 760.100
28/08/2017 2,60 2,74 2,41 2,74 +6,20% 12,69% 1.323.900